PRECIGEN, INC. Payments to Acquire Investments
PRECIGEN, INC. (PGEN) reported Payments to Acquire Investments of $81.54 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2026-08-04
- PRECIGEN, INC. payments to acquire investments for the quarter ending 2026-06-30 was $47.66M, a 67.44% increase year-over-year.
- PRECIGEN, INC. payments to acquire investments for the quarter ending 2026-03-31 was $33.87M, a 225.46% increase year-over-year.
- PRECIGEN, INC. payments to acquire investments for the quarter ending 2025-12-31 was $23.86M, a 78.76% decline year-over-year.
- PRECIGEN, INC. payments to acquire investments for the quarter ending 2025-09-30 was $145.27M, a 526.68% increase year-over-year.
- PRECIGEN, INC. payments to acquire investments for fiscal 2025 was $208.01M, a 11.11% increase from fiscal 2024.
- PRECIGEN, INC. payments to acquire investments for fiscal 2024 was $187.21M, a 1.18% increase from fiscal 2023.
- PRECIGEN, INC. payments to acquire investments for fiscal 2023 was $185.03M.
- PRECIGEN, INC. payments to acquire investments for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $47.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $81.54M 10-Q · filed 2026-08-04 | $105.40M derived: sum of 3 quarters · filed 2026-08-04 | $250.67M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $33.87M 10-Q · filed 2026-05-13 | $57.73M derived: sum of 2 quarters · filed 2026-05-13 | $203.00M derived: sum of 3 quarters · filed 2026-05-13 | $231.47M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $23.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $169.13M derived: sum of 2 quarters · filed 2026-03-25 | $197.60M derived: sum of 3 quarters · filed 2026-08-04 | $208.01M 10-K · filed 2026-03-25 |
| 2025-09-30 | $145.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $173.74M derived: sum of 2 quarters · filed 2026-08-04 | $184.15M 10-Q · filed 2025-11-13 | $296.51M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $28.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $38.88M 10-Q · filed 2026-08-04 | $151.24M derived: sum of 3 quarters · filed 2026-08-04 | $174.42M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $10.41M 10-Q · filed 2026-05-13 | $122.77M derived: sum of 2 quarters · filed 2026-05-13 | $145.95M derived: sum of 3 quarters · filed 2026-05-13 | $180.42M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $112.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $135.54M derived: sum of 2 quarters · filed 2026-03-25 | $170.02M derived: sum of 3 quarters · filed 2026-03-25 | $187.21M 10-K · filed 2026-03-25 |
| 2024-09-30 | $23.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $57.66M derived: sum of 2 quarters · filed 2025-11-13 | $74.84M 10-Q · filed 2025-11-13 | $106.17M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | $34.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $51.66M 10-Q · filed 2025-08-12 | $82.99M derived: sum of 3 quarters · filed 2026-03-25 | $108.13M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | $17.19M 10-Q · filed 2025-05-14 | $48.52M derived: sum of 2 quarters · filed 2026-03-25 | $73.65M derived: sum of 3 quarters · filed 2026-03-25 | $94.05M derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | $31.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $56.46M derived: sum of 2 quarters · filed 2026-03-25 | $76.86M derived: sum of 3 quarters · filed 2026-03-25 | $185.03M 10-K · filed 2026-03-25 |
| 2023-09-30 | $25.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $45.53M derived: sum of 2 quarters · filed 2024-11-14 | $153.70M 10-Q · filed 2024-11-14 | $153.70M derived: sum of 4 quarters · filed 2025-03-19 |
| 2023-06-30 | $20.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $128.56M 10-Q · filed 2024-08-14 | $128.56M derived: sum of 3 quarters · filed 2025-03-19 | $128.56M derived: sum of 4 quarters · filed 2025-03-19 |
| 2023-03-31 | $108.16M 10-Q · filed 2024-05-14 | $108.16M derived: sum of 2 quarters · filed 2025-03-19 | $108.16M derived: sum of 3 quarters · filed 2025-03-19 | $108.16M derived: sum of 4 quarters · filed 2025-03-19 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $0.00 derived: sum of 2 quarters · filed 2025-03-19 | $0.00 derived: sum of 3 quarters · filed 2025-03-19 | $0.00 10-K · filed 2025-03-19 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2024-03-19 | $0.00 derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-03-19 | $0.00 derived: sum of 3 quarters · filed 2024-03-19 | $0.00 derived: sum of 4 quarters · filed 2024-03-19 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $0.00 derived: sum of 2 quarters · filed 2024-03-19 | $0.00 derived: sum of 3 quarters · filed 2024-03-19 | $174.22M 10-K · filed 2024-03-19 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $174.22M 10-Q · filed 2022-11-09 | $174.22M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $174.22M 10-Q · filed 2022-08-08 | $174.22M derived: sum of 3 quarters · filed 2023-03-06 | $212.32M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $174.22M 10-Q · filed 2022-05-09 | $174.22M derived: sum of 2 quarters · filed 2023-03-06 | $212.32M derived: sum of 3 quarters · filed 2023-03-06 | $226.31M derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $38.10M derived: sum of 2 quarters · filed 2023-03-06 | $52.09M derived: sum of 3 quarters · filed 2023-03-06 | $171.36M 10-K · filed 2023-03-06 |
| 2020-09-30 | $38.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $52.09M derived: sum of 2 quarters · filed 2021-11-08 | $171.36M 10-Q · filed 2021-11-08 | $171.36M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $13.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $133.26M 10-Q · filed 2021-08-09 | $133.26M derived: sum of 3 quarters · filed 2022-03-01 | $151.17M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $119.27M 10-Q · filed 2021-05-10 | $119.27M derived: sum of 2 quarters · filed 2022-03-01 | $137.18M derived: sum of 3 quarters · filed 2022-03-01 | $174.34M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $17.91M derived: sum of 2 quarters · filed 2022-03-01 | $55.07M derived: sum of 3 quarters · filed 2022-03-01 | $55.07M 10-K · filed 2022-03-01 |
| 2019-09-30 | $17.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $55.07M derived: sum of 2 quarters · filed 2020-11-09 | $55.07M 10-Q · filed 2020-11-09 | $55.07M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $37.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $37.16M 10-Q · filed 2020-08-10 | $37.16M derived: sum of 3 quarters · filed 2021-03-01 | $215.77M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $178.60M derived: sum of 3 quarters · filed 2021-03-01 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $178.60M derived: sum of 2 quarters · filed 2021-03-01 | $178.68M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $178.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $178.68M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $76.00K 10-Q · filed 2019-08-09 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $0.00 derived: sum of 2 quarters · filed 2020-03-02 | $0.00 10-K · filed 2020-03-02 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-13 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $75.25M 10-K · filed 2019-03-01 | ||
| 2016-09-30 | $75.25M 10-Q · filed 2017-11-09 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $181.57M derived: sum of 2 quarters · filed 2018-03-01 | $181.57M 10-K · filed 2018-03-01 | |
| 2015-09-30 | $181.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $181.57M 10-Q · filed 2016-11-09 | ||
| 2015-06-30 | $0.00 10-Q · filed 2015-08-10 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 derived: sum of 2 quarters · filed 2017-03-01 | $60.48M 10-K · filed 2017-03-01 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $60.48M 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | $60.48M 10-Q · filed 2015-08-10 | |||
| 2013-12-31 | $747.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $138.73M derived: sum of 2 quarters · filed 2016-02-29 | $233.98M 10-K · filed 2016-02-29 | |
| 2013-09-30 | $137.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $233.23M 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $95.25M 10-Q · filed 2014-08-14 | |||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $2.00K 10-K · filed 2015-03-02 | ||
| 2012-09-30 | $2.00K 10-Q · filed 2013-11-07 | |||
| 2011-12-31 | $188.00K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |